search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Akari Therapeutics, Plc

    (NASDAQ:AKTX)

    $0.99

    $0.02

    1.55%

    Akari Therapeutics, Plc Chart

    AKTX Stock Price Today

    Akari Therapeutics, Plc (AKTX) stock rallied over 1.55% intraday to trade at $0.99 a share on NASDAQ. The stock opened with a gain of 2.06% at $0.97 and touched an intraday high of $1.03, rising 2.06% against the last close of $0.97. The stock went to a low of $0.95 during the session.

    Stock Snapshot

    $0.97

    Prev. Close

    57.45 Million

    Market Cap

    $0.95

    Day Low

    $0.97

    Open

    47.65 Million

    Number of Shares

    $1.03

    Day High

    -

    P/E ratio

    -0.42

    EPS (TTM)

    0.28

    Cash Flow per Share

    0.41

    Free Float in %

    0.24

    Book Value

    87,921

    Volume

    Akari Therapeutics, Plc Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$0.97$1.03$0.95$0.98588,000
    2022-06-22$0.97$1.01$0.955$0.9757,500
    2022-06-21$0.96$1.01$0.96$0.9824,300
    2022-06-17$0.96$1.03$0.96$1.0110,200
    2022-06-16$1.12$1.12$0.963$0.99226,600
    2022-06-15$0.96$0.982$0.956$0.9722,300
    2022-06-14$0.99$1$0.97$128,900
    2022-06-13$1$1.03$0.95$0.98999,900
    2022-06-10$1.04$1.079$1$1.02139,200
    2022-06-09$1.07$1.14$1.05$1.05559,600

    Contact Details

    75/76 Wimpole Street
    London W1G 9RT
    United Kingdom

    Webiste:AKTX

    44 20 8004 0270

    Company Information

    Employees-

    Beta1.27

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2020-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barre syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

    Frequently Asked Questions

    icon

    What is the current Akari Therapeutics, Plc (AKTX) stock price?

    Akari Therapeutics, Plc (NASDAQ: AKTX) stock price is $0.99 as of the last check on Thursday, June 23. During the trading session, AKTX stock reached the peak price of $1.03 while $0.95 was the lowest point it dropped to.

    icon

    AKTX's industry and sector of operation?

    The NASDAQ listed AKTX is part of Pharmaceuticals industry that operates in the broader Health Care sector. Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barre syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid.

    icon

    Who are the executives of AKTX?

    Mr. Clive Richardson
    COO, CEO & Director
    Dr. Ray Prudo-Chlebosz M.D.
    Exec. Chairman
    Dr. Torsten Hombeck
    Chief Financial Officer
    Ms. Rachelle Suzanne Jacques
    Pres, CEO & Director

    icon

    What is the AKTX stock price today?

    AKTX stock traded closed the last session at $0.985, which is $0.02 or 1.55% lower than its previous close of $0.97. AKTX's current trading price is 3.68% lower than its 52-week high of $1.88 where as its distance from 52-week low of 0.95% is -47.61%.

    icon

    How many employees does AKTX have?

    Number of AKTX employees currently stands at -. AKTX operates from 75/76 Wimpole Street, London W1G 9RT, United Kingdom.

    icon

    Link for AKTX official website?

    Official Webiste of $AKTX is: https://www.akaritx.com

    icon

    How do I contact AKTX?

    AKTX could be contacted at AKTX operates from 75/76 Wimpole Street, London W1G 9RT, United Kingdom, or at phone #44 20 8004 0270 and can also be accessed through its website.

    icon

    How many shares of AKTX are traded daily?

    AKTX stock volume for the day was 87,921 shares while in the previous session number of AKTX shares traded was 88,000 . The average number of AKTX shares traded daily for last 3 months was 54.46 Thousands.

    icon

    How much did AKTX change today?

    The percentage change in AKTX stock occurred in the recent session was 1.55% while the dollar amount for the price change in AKTX stock was $0.02.

    icon

    What price range AKTX stock been trading in?

    In the recent session, the day high for AKTX stock was $1.03 while the low for AKTX stock touched on the day was $0.95.

    icon

    What is the market cap of AKTX currently?

    The market value of AKTX currently stands at 57.45 Million with its latest stock price at $0.99 and 47.65 Million of its shares outstanding.